로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > FGF-23

FGF-23

요약

Name:Fibroblast growth factor 23
Target Synonym:HFTC2,Tumor-Derived Hypophosphatemia Inducing Factor,UNQ3027/PRO9828,Tumor-derived hypophosphatemia-inducing factor,HYPF,FGF23,Fibroblast Growth Factor 23,Phosphatonin,FGF-23,HPDR2,PHPTC,ADHR,FGFN
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:0
Lastest Research Phase:Approved

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
태그별:
결합물별:
제품번호 제품 설명 구조 순도 특징
FG3-H52H3 Human Human FGF-23 (R179Q) Protein, His Tag
FG3-H52H3-structure
FG3-H52H3-sds

Synonym Name

FGF23,HYPF,FGF-23,ADHR,HPDR2

Background

Fibroblast growth factor 23 (FGF23) is is an endocrine member of the family of FGFs and mainly produced in the bone and, upon secretion, forms a complex with a FGF receptor and coreceptor αKlotho. FGF23 can exert several endocrine functions, such as acting as a hormone on the kidney, stimulating phosphate excretion and suppressing formation of 1,25(OH)2D3, active vitamin D. Moreover, it has paracrine activities on several cell types, including neutrophils and hepatocytes. FGF23 and phosphate have been revealed to be factors relevant in cancer. FGF23 is particularly significant for those forms of cancer primarily affecting bone (e.g., multiple myeloma) or characterized by bone metastasis.

Clinical and Translational Updates

This web search service is supported by Google Inc.

totop